Share on LinkedInShare on LinkedIn

ARTICLE · 11 NOVEMBER 2025

Litigation-Ready IP: Why MedTech Companies Must Think Beyond Patent Filing

Marks & Clerk
Marks & Clerk
Contributor
Marks & Clerk

Marks & Clerk

Marks & Clerk LLP was founded in 1887 by George Croydon Marks, who was joined in partnership by...

View firm profile
Explore more from Marks & Clerk

In the world of MedTech, intellectual property can sometimes be treated as little more than a box-ticking exercise: file a patent, secure protection, and move on.

United KingdomIntellectual Property

In the world of MedTech, intellectual property can sometimes be treated as little more than a box-ticking exercise: file a patent, secure protection, and move on. This is particularly true for start-ups who may want to use the existence of a patent portfolio primarily to help secure investment funding. However, the reality can be far more complex. Indeed, it is essential to pause and consider whether the patents in issue would in fact hold up under the intense scrutiny of litigation. A litigation-ready IP strategy goes beyond mere filing: it ensures that patents are enforceable, defensible, and aligned with the company's commercial objectives. In the MedTech sector, disputes are frequent and the sums at stake can be very high; it is important to get things right.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from